Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.
about
Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendationsA clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancersSpotlight on decitabine for myelodysplastic syndromes in Chinese patientsPediatric AML: From Biology to Clinical ManagementPredicting response to epigenetic therapyIntegrative network modeling approaches to personalized cancer medicineEpigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia.Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapy.Vitamin C increases viral mimicry induced by 5-aza-2'-deoxycytidine.Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolution.Deacetylase inhibitors for the treatment of myelodysplastic syndromes.Drugging the pain epigenome.The risk of infections in patients with myelodysplastic syndromes in 2016.Myelodysplastic Syndromes: Updates and Nuances.Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management.A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes.Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working Party.A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts.A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation.Encouraging results with the compassionate use of hydralazine/valproate (TRANSKRIP™) as epigenetic treatment for myelodysplastic syndrome (MDS).Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia.Incidence and risk of hematologic toxicities with hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukopenia: A systematic review and meta-analysis
P2860
Q24605618-660DD3E4-9217-440A-A3EE-A36109130DCFQ26743743-44955D68-D368-4927-8C33-260B36B78403Q26778454-2B03C46F-B9E7-40EB-8477-3A310A5FBE6DQ26799773-93DD12B5-CA3A-4412-A6A3-36D7B9FDD7C8Q27027751-1688B30C-FC67-4E57-AA0F-0CA2E2C9B56CQ28602016-CBFA772E-4669-4419-8A0C-40B34885A197Q34350209-1474644A-E909-4A2D-BFC3-CBA29B4333C6Q36283696-0FEA281E-ED66-4D4E-9813-12E053097F9BQ37264298-53437BE0-AF57-4001-B9A9-F0779D553FCFQ38218055-D3FF9383-5438-45FA-A304-87723FBF2DB2Q38233492-5CC43A1D-3DAF-4470-AB88-18A3C1D31D37Q38761806-E4BBD15C-033E-48DE-9B6E-37EBB6E5280AQ38813702-ECE31322-5564-4619-AC4C-2B8B8CA15B46Q38965973-06E32C84-1D72-44FE-8BDB-0666B822AB81Q40420210-71AFA017-A00B-4743-AB12-124CDA21F8E1Q40504613-3575D9E1-C53A-4A45-BF42-7CE8D2F3D19FQ40572555-01717B3D-AB15-4440-8B26-8EDB2E05F335Q45624632-D009B7BD-5D6C-407E-86D3-67D4A4C6B930Q47099325-AC577F28-8E15-4B8A-9BBF-0982C96FD9DCQ47264910-DAA0BDE3-D3AB-445D-88E5-A37DF12FB767Q48198254-6BA624FB-170F-49A3-864B-E9E48EAB291AQ49401381-1455BA03-EDCA-49C1-ACE4-04E49AC653A6Q58706592-7911DA2E-A1FB-4CFE-81F8-65593280E24B
P2860
Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Comparative analysis between a ...... of myelodysplastic syndromes.
@en
type
label
Comparative analysis between a ...... of myelodysplastic syndromes.
@en
prefLabel
Comparative analysis between a ...... of myelodysplastic syndromes.
@en
P2093
P2860
P50
P356
P1476
Comparative analysis between a ...... t of myelodysplastic syndromes
@en
P2093
Byung-Soo Kim
Chu-Myoung Seong
Chul Soo Kim
Hong Ghi Lee
Hyeon Gyu Yi
Hyeoung-Joon Kim
Jae Hoon Lee
Jeong-Ok Lee
Jinny Park
P2860
P304
P356
10.1111/BJH.12256
P407
P577
2013-02-21T00:00:00Z